Merck

Our #SkillsFirst approach offers career opportunities focused on unique experiences beyond a traditional four-year degree. Explore open roles and build an extraordinary future at our company: http://merck.us/3VPdUbp #MerckCareers

Today, we announced the European Commission’s approval of a new treatment option for #PulmonaryArterialHypertension (#PAH). Learn more: http://merck.us/4fWWIJ7

Despite the well-documented benefits of vaccines, hesitancy is a longstanding public health issue that can result in under-vaccination and global disease outbreaks. These challenges bring new opportunities to improve our approach and be better advocates for all our communities. Learn more about how we’re helping build vaccine confidence: http://merck.us/3MeJLfY

We're honored to be recognized on TIME's inaugural list of the World’s Most Sustainable Companies for our commitment to enabling a safe and healthy future for people and communities around the world. Learn more about our approach to positively impacting society and delivering long-term business value for all of our stakeholders in our 2023/2024 Impact Report: http://merck.us/4dEJG0W

Working on behalf of patients with rare diseases is a source of deep inspiration for us. We recognize the immense value of supportive communities for people with rare diseases, like #PAH. Every journey is different, but connecting and sharing the experience can make it less isolating. This weekend, we’re proud to join #PHA2024 and show our support for people living with #PAH and their families.

We build the bridges that connect our science with health care professionals and patients who need them. If you’re interested in being a part of this incredible journey, explore opportunities with us now: http://merck.us/3VCQrc7 #MerckCareers #LifeAtMerck

In the 1950s, Marilyn’s friend contracted polio, an infectious disease that may cause flu-like symptoms, weakness in the limbs or paralysis. This #NIAM, hear why she encourages others to speak with a doctor about #vaccines.

Today, we announced the acquisition of a novel investigational bispecific antibody from Curon Biopharmaceutical. Learn how this acquisition further expands and diversifies our growing pipeline, with potential applications in B-cell malignancies and autoimmune diseases: http://merck.us/3yuXiwQ

Listen to our newest episode of #CareerOnPurpose podcast as we speak with our chief diversity and inclusion officer Celeste Warren (She/Her) about our company’s efforts toward building an inclusive workforce. Check out the full episode to gain valuable insights about engaging talent from all backgrounds, education levels and job interests: http://merck.us/3Ahuit1

Congratulations to Jannie Oosthuizen, president of our Human Health U.S. business, for receiving an honorary doctorate in pharmacy from his alma mater North-West University for his global leadership and impact for patients! Jannie’s work over the last three decades has made a vital difference to people and communities around the world. We’re inspired by his continued commitment to helping our company deliver on our purpose of saving and improving lives.